Educational Activities Archives

This session explores the clinical and policy landscape of providing medications for opioid use disorder (MOUD) in jails, prisons, and reentry settings. Dr. Arthur Robin Williams and Dr. Peter Treitler review recent research on the effectiveness of MOUD in reducing overdose and improving post-release treatment engagement. The session highlights key differences among methadone, buprenorphine, and extended-release naltrexone, including regulatory and logistical considerations unique to correctional environments. Learners will examine policy updates, case-based examples, and implementation strategies that support evidence-based treatment access. The session also addresses interdisciplinary collaboration, diversion concerns, and continuity of care across incarceration and reentry.

This activity focuses on the assessment and management of pain using multimodal treatments that reduce the reliance on opioid analgesics. Learners are introduced to information on the principles, mechanisms, and frameworks relevant to multimodal analgesia, with an emphasis on non-pharmacological techniques and non-opioid medications. Applications of multimodal treatments for pain to various clinical settings are reviewed, as well as relevant case studies for the treatment of acute and sub-acute pain.

This podcast will be published on the SAEM website and in promotional materials, such as our weekly newsletter, to inform learners of the activity’s contents and goals.

The OUD Cascade of Care is a public health framework for monitoring population-level outcomes with an emphasis on MOUD initiation and retention. Buprenorphine treatment can be tailored under the Cascade framework based on patient risk level. For instance, patients with active fentanyl use who are naïve to buprenorphine often need more intensive services early in treatment compared to patients entering care already on buprenorphine, whether prescribed or otherwise.

The Collaborative Care Model (CoCM) is an evidence-based approach to deliver behavioral healthcare in primary care settings. This model has been adapted to address substance use disorders in primary medical settings. CoCM requires a team of providers; trained primary care providers (PCP) work with embedded behavioral health care managers (BHCM) to provide a range of effective treatment, including evidence-based medication and/or psychosocial treatments.

This presentation will review the Collaborative Care Model (CoCM), which is an evidence-based approach to delivering behavioral healthcare in primary care settings. This model has been adapted to address substance use disorders in primary medical settings. CoCM requires a team of providers; trained primary care providers (PCP) work with embedded behavioral health care managers (BHCM) to provide a range of effective treatments, including evidence-based medication and/or psychosocial treatments, and a psychiatric consultant who engages with the team primarily through indirect care. Implementation and clinical considerations for CoCM for substance use disorders will be reviewed.